statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Unveiling 6 Analyst Insights On Capricor Therapeutics

Latest Ratings for CAPR
 DateFirmActionFromTo Jan 2022HC Wainwright & Co.MaintainsBuy Oct 2021HC Wainwright & Co.MaintainsBuy Jul 2019HC Wainwright & Co.MaintainsBuy
 View More Analyst Ratings...

What's Going On With Capricor Therapeutics Stock Friday?

The biotechnology company said deramiocel increased cardiac function based on several different measures.
read more...

What's Going On With Capricor Therapeutics Stock Tuesday?

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is trading higher Tuesday after the company announced three-year results from the ongoing HOPE-2 open-label extension read more...

Expert Ratings For Capricor Therapeutics

Short Interest in Capricor Therapeutics Inc (NASDAQ:CAPR) Grows By 19.6%

Capricor Therapeutics Inc (NASDAQ:CAPR - Get Free Report) saw a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 3,230,000 shares, an...

Capricor Therapeutics (CAPR, $6.31) RSI Indicator left the overbought zone on March 26, 2024

This is a signal that CAPR's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Capricor Therapeutics (CAPR, $6.63) RSI Indicator left the overbought zone on March 25, 2024

Capricor Therapeutics to Present at Upcoming Investor Conferences

SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and...

Capricor Therapeutics Inc to Post FY2024 Earnings of ($0.84) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:CAPR)

Capricor Therapeutics Inc (NASDAQ:CAPR  Free Report)  Stock analysts at Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for shares of Capricor Therapeutics in...

The volume for Capricor Therapeutics stock increased for one day, resulting in a record-breaking daily growth of 249% of the 65-Day Volume Moving Average

CAPR's total volume now sits at 926.7K. The +0.44% price change was insignificant, leaving IBM's price at $6.79...

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Volume	276,092.00
52-Wk High	$8.22
52-Wk Low	$2.68

CAPR Capricor Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals